BACKGROUND: Metastatic melanoma has shown only limited responsiveness to chemotherapy or immunotherapy. The most commonly used single-agent chemotherapy comes from the nitrosourea group of agents and provides response rates of less than 20%. Several cytotoxic agents have been combined with no dramatic benefit. https://www.littleloungeres.shop/product-category/outerwear/
Web Directory Categories
Web Directory Search
New Site Listings